Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Non Operating Investment Income (2024)

Tonix Pharmaceuticals Holding has reported Non Operating Investment Income over the past 1 years, most recently at -$855000.0 for Q2 2024.

  • Quarterly results put Non Operating Investment Income at -$855000.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $6.1 million (changed N/A YoY), and the annual figure for FY2024 was $6.1 million, changed.
  • Non Operating Investment Income for Q2 2024 was -$855000.0 at Tonix Pharmaceuticals Holding, down from $7.0 million in the prior quarter.
  • Over the last five years, Non Operating Investment Income for TNXP hit a ceiling of $7.0 million in Q1 2024 and a floor of -$855000.0 in Q2 2024.